Seratec has been leading the way as a Contract Development and Manufacturing Organization (CDMO) for API solutions since 1970. Their passion for APIs goes beyond mere science. They have gained international recognition for their French expertise in producing active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. Seratec not only designs, develops, and registers pharmacologically active molecules with the American (FDA), European (EMA), and national (ANSM) drug agencies, but also ensures API production adhering to the Good Manufacturing Practices (GMP) quality standards. Operating in the Biopharma, Manufacturing, and Pharmaceutical industries, Seratec's close collaboration with pharmaceutical laboratories reflects the high standards and rigorous demands that they meet. With a slogan "#OEYT - Our excellence, your trust," Seratec continues to solidify its position as a trusted partner in the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for Seratec.